secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001628280-24-037384
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks shareholders approve reverse split; board sets 1:40 ratio
-------------------------------------------------------------------------

- Reverse stock split approved by shareholders (4.7B votes for); board set ratio at 1:40.
- Split effective Aug 19; shares trade split-adjusted Aug 20 under symbol DNA.
- Every 40 shares of Common Stock combined into 1; fractional shares paid in cash.
- Warrants adjusted: exercise price $460/share (or $11.50 per warrant); 40 warrants per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024037384/0001628280-24-037384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024037384/dna-20240814.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-037384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer